Results 81 to 90 of about 5,040 (223)
Risk factors for reoperation after relief of congenital subaortic stenosis [PDF]
Background: Congenital subaortic stenosis entails a lesion spectrum, ranging from an isolated obstructive membrane, to complex tunnel narrowing of the left outflow associated with other cardiac defects.
Bauersfeld, Urs +6 more
core
ABSTRACT Alcohol septal ablation is a well‐established treatment method for patients with hypertrophic cardiomyopathy. We present a case report of a patient with transposition of the great arteries (TGA) after a Mustard procedure, who developed significant right ventricular outflow tract obstruction (RVOTO), functionally resembling subaortic stenosis ...
Vera Osberghaus +6 more
wiley +1 more source
Objective: During septal myectomy, once the heart is arrested and drained of blood on cardiopulmonary bypass, transesophageal echocardiography can no longer assess septal thickness.
Katherine G. Phillips, MD +9 more
doaj +1 more source
Non-pharmaceutical Interventions for Hypertrophic Cardiomyopathy: A Mini Review
Hypertrophic cardiomyopathy is an inherited cardiovascular disease, and 70% of patients have left ventricular outflow tract obstruction. Ventricular septal myectomy has been the gold standard treatment for most patients with refractory symptoms.
Miaomiao He +5 more
doaj +1 more source
Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation [PDF]
BACKGROUND: Ischemia occurs frequently in hypertrophic cardiomyopathy (HCM) without evidence of epicardial stenosis. This study evaluates the hypothesis that the occurrence of ischemia in HCM is related to remodeling of the coronary ...
Birgelen, C. (Clemens) von +7 more
core +1 more source
Aims To evaluate the real‐world efficacy and safety of low‐dose (2.5 mg) mavacamten initiation in Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Methods and Results This single‐center observational study (Zhongshan Hospital, China; Oct 2024–Apr 2025) enrolled 72 symptomatic oHCM patients (NYHA II/III, LVEF ≥ 55 ...
Wenlong Yang +9 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala +1 more
wiley +1 more source
Introduction Mitral annular calcification (MAC) presents a significant surgical challenge, often rendering conventional surgery high risk. The presence of a heavily calcified, rigid, and friable annulus significantly increases the risk of complications such as atrioventricular groove disruption, annular rupture, and paravalvular leak.
Laith Kayyal +9 more
wiley +1 more source
Background Percutaneous intramyocardial (PIM) septal pulsed field ablation (SPFA) represents an innovative technique for the management of hypertrophic obstructive cardiomyopathy. However, the paucity of pertinent animal models has impeded comprehensive investigation. This study aimed to assess the safety, efficacy, and feasibility of PIM‐SPFA, as well
Xing-an Zhao +10 more
wiley +1 more source
Etude de l'évolution des patients porteurs d'une cardiomyopathie hypertrophique obstructive (CMHO) après alcoolisation septale [PDF]
La cardiomyopathie hypertrophique (CMH) est la maladie cardiaque monogénique la plus fréquente, touchant environ 1 individu sur 500 dans la population (1,2).
CARREL, L.
core

